-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fosciclopirox in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fosciclopirox in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fosciclopirox in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Cytarabine Hydrochloride + Daunorubicin Hydrochloride) in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Cytarabine Hydrochloride + Daunorubicin Hydrochloride) in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Cytarabine Hydrochloride...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fosciclopirox in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fosciclopirox in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Fosciclopirox in Solid Tumor Drug Details: CPX-POM (Ciclopirox prodrug) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fosciclopirox in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fosciclopirox in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Fosciclopirox in Relapsed Acute Myeloid Leukemia Drug Details: CPX-POM (Ciclopirox prodrug)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fosciclopirox in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fosciclopirox in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Fosciclopirox in Refractory Acute Myeloid Leukemia Drug Details: CPX-POM (Ciclopirox prodrug)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Cytarabine Hydrochloride + Daunorubicin Hydrochloride) in Relapsed Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.(Cytarabine Hydrochloride + Daunorubicin Hydrochloride) in Relapsed Acute Myeloid Leukemia Drug Details: Cytarabine hydrochloride and daunorubicin...
-
Product Insights
Net Present Value Model: Vyxeos
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Vyxeos Drug Details Cytarabine hydrochloride and...